Evidence map›Paper›PMID 34071278›Full record

ArticleDiagnostics (Basel, Switzerland)2021

Prospective Observational COVID-19 Screening and Monitoring of Asymptomatic Cancer Center Health-Care Workers with a Rapid Serological Test.

Angelo Virgilio Paradiso, Simona De Summa, Nicola Silvestris, Stefania Tommasi, Antonio Tufaro, Angela Maria Vittoria Larocca, Vincenzo D'Addabbo, Donata Raffaele, Vito Cafagna, Vito Michele Garrisi and 1 more

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. SARS-CoV-2 Infection in Health Workers: Analysis from Verona SIEROEPID Study during the Pre-Vaccination Era.International journal of environmental research and public health · 2021
    Article
  4. Seroprevalence of SARS-CoV-2 Antibodies in Adults and Healthcare Workers in Southern Italy.International journal of environmental research and public health · 2021
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Angelo Virgilio ParadisoScientific Direction, IRCCS Istituto Tumori "Giovanni Paolo II", 70124 Bari, Italy.ORCID 0000-0001-6495-2295
Simona De SummaMolecular Diagnostics and Pharmacogenetics Unit, IRCCS Istituto Tumori "Giovanni Paolo II", 70124 Bari, Italy.ORCID 0000-0001-9607-3754
Nicola SilvestrisUnit of Internal Medicine "Guido Baccelli", Department of Biomedical Sciences and Human Oncology, University of Bari, 70124 Bari, Italy.
Stefania TommasiMolecular Diagnostics and Pharmacogenetics Unit, IRCCS Istituto Tumori "Giovanni Paolo II", 70124 Bari, Italy.ORCID 0000-0002-2157-2978
Antonio TufaroExperimental Oncology and Biobank Management Unit, Institutional BioBank, IRCCS Istituto Tumori "Giovanni Paolo II", 70124 Bari, Italy.
Angela Maria Vittoria LaroccaHygiene Unit, University Hospital "Policlinico" of Bari, 70124 Bari, Italy.
Vincenzo D'AddabboProfessioni Sanitarie Unit, IRCCS Istituto Tumori "Giovanni Paolo II", 70124 Bari, Italy.
Donata RaffaeleScientific Direction, IRCCS Istituto Tumori "Giovanni Paolo II", 70124 Bari, Italy.
Vito CafagnaClinical Pathology Laboratory, IRCCS Istituto Tumori "Giovanni Paolo II", 70124 Bari, Italy.
Vito Michele GarrisiClinical Pathology Laboratory, IRCCS Istituto Tumori "Giovanni Paolo II", 70124 Bari, Italy.ORCID 0000-0001-8113-5959
Giuseppe De PalmaExperimental Oncology and Biobank Management Unit, Institutional BioBank, IRCCS Istituto Tumori "Giovanni Paolo II", 70124 Bari, Italy.ORCID 0000-0002-6108-096X
Istituto Tumori Bari · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Health-care workers (HCW) are at high risk for SARS-CoV-2 infection and, if asymptomatic, for transmitting the virus to fragile cancer patients. We monitored all asymptomatic HCWs of a cancer institute (94% of all employees agreed to enter the study) with the rapid serological test, VivaDiag

Indexed as

cancer centerCOVID-19health-care workersSARS-CoV-2serological test

Identifiers

PMID34071278
PMCPMC8230120
OpenAlexW3165608554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.